Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cochlear.
RELATED STOCKHEAD STORIES
News
Traders’ Diary: Bloodshed last week, Qantas this week
Health & Biotech
ScoPo’s Powerplays: CSL, Cochlear drag ASX health sector up in mixed start to reporting season
News
ASX Large Caps: Local bourse up as China cuts key rate; aftermarket stock GUD top gainer, up by 15pc
News
ASX Earnings Wrap: Reckon jumps 13pc; Pro Medicus keeps delivering, up almost 40pc this year
News
Traders’ Diary: Everything you need to get ready for the week ahead
News
The Ethical Investor: Why Australian Ethical Investment dumped Lendlease, but loves Woolies
News
ASX Large Caps: Fake nickel found at LME; coal stocks lift as ASX erases yesterday’s losses
Experts
What Morningstar’s moat rankings mean, and how they can be used to make investment decisions
Health & Biotech
ScoPo’s Powerplays: ASX health stocks drop 0.3% but reporting season gives cause for optimism
News
ASX Large Caps: Shares tumble 1pc as CBA causes selloff in ASX bank stocks
News
ASX Small Caps Lunch Wrap: Who else just wants to watch it all burn today?
News
ALL you need to know about China’s return in 2023 and the 35 ASX names most exposed to success
Health & Biotech
ASX Health Stocks: Kazia gets published in renowned Journal, Cochlear rejects ACCC’s claims
Experts
ScoPo’s Powerplays: Hold the presses as KKR pulls bid on Ramsay Healthcare
News
ASX Large Caps: Oil, coal stocks rally as the ASX cruises to a 1pc gain for the week
News
ASX Large Caps: Energy gain offset by losses in Tech and Healthcare
Experts